Featured Links  BLP25 Liposome  Vaccine Video  Stock Price  News Releases  Upcoming Events  Privacy Statement

Biomira Inc. is a biotechnology company applying its leading technology in immunotherapy and organic chemistry for the development of cancer therapeutics. The Company's commitment to the development of products for the treatment of cancer is currently focused on synthetic therapeutic vaccines and innovative strategies for immunotherapeutic treatment of cancer. We are The Cancer Vaccine People™.

Top Stories:

	January 27, 2006 BIOMIRA ANNOUNCES U.S. $16.1 MILLION FINANCING
	January 26, 2006 Conference Call Replay Information - Biomira Inc.